RBX2660
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RBX2660, covering 2024-08-07 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection [Phase 3]